Dr Ahmar Zaidi: How Social Determinants Could Limit Access to Gene Therapy for Sickle Cell
September 17, 2019 – 
The only thing that should matter in these patients is their genetic code, but often it’s your zip code that really restrains your ability to access the healthcare you deserve, explained Ahmar Zaidi, MD, pediatric hematologist-oncologist, Comprehensive Sickle Cell Center, Children's Hospital of Michigan, when discussing the possibility of a gene therapy for sickle cell.
Dr Daniel Kantor on the Real-World Value of MS Disease Registries
September 16, 2019 – 
Since the introduction of disease-modifying therapies for multiple sclerosis (MS), evidence from disease registries has shown how the therapies work in the real world and reduce the effect of MS on people’s lives, according to Daniel Kantor, MD, president of Kantor Neurology.
Lani Alison Discusses How the OCM Allowed for Better Integration of Palliative Care
September 15, 2019 – 
Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, explains how the implementation of the Oncology Care Model (OCM) allowed practices to better integrate palliative care.
Dr Albert Rizzo Outlines Prevalence of Overtreatment, Undertreatment in COPD
September 13, 2019 – 
Albert Rizzo, MD, FACP, chief medical officer for the American Lung Association, discusses the prevalence of overtreatment and undertreatment in chronic obstructive pulmonary disease (COPD).
Dr Ajai Chari Discusses the Importance of Real-World Evidence in Multiple Myeloma
September 11, 2019 – 
Real-world outcomes are important because the populations included in clinical trials rarely reflect the populations actually being treated in the clinic, said Ajai Chari, MD, associate professor of medicine, Hematology and Medical Oncology, Mount Sinai Hospital.
Dr Iuliana Shapira Offers Examples of How Innovation Can Transform Cancer Care Delivery
September 10, 2019 – 
Innovation that transform cancer care delivery have to be multi-level, explained Iuliana Shapira, MD, chief medical officer, Regional Cancer Care Associates.
Dr Daniel Kantor Explains How MS Measurement and Prediction Can Lead to Precision Medicine
September 10, 2019 – 
Using imaging, laboratory testing, and predictive models, the field of multiple sclerosis (MS) is getting closer to predicting the course of MS and, eventually, the best medication for a given patient, said Daniel Kantor, MD, president of Kantor Neurology.
Michael Thompson Highlights Employer Efforts to Address Mental Health Issues
September 08, 2019 – 
Employers have become more aware of how key an issue mental health is for employees and they are relieving some of the perceived stigma by making it okay to talk about mental health issues, said Michael Thompson, president and chief executive officer of the National Alliance of Healthcare Purchaser Coalitions.
Dr John Fox Outlines Management Challenges in Multiple Myeloma
September 07, 2019 – 
John Fox, MD, MHA, vice president of Clinical Transformation at Spectrum Health, discusses management challenges still facing providers treating multiple myeloma.
Dr Daniel Kantor Highlights MS Treatments and What Is in the Pipeline
September 07, 2019 – 
The field of treatments for multiple sclerosis (MS) has grown quickly in the last 30 years, but the next new class of therapies probably won’t come to market for at least another year and a half, said Daniel Kantor, MD, president of Kantor Neurology.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.